Biblio

2024
Del Vecchio V, La Noce M, Tirino V. ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation. Methods Mol Biol. 2024;2777:83-89.
Du Y, Zhao H, Feng N, Zheng D, Khan A, Zhou H, Deng P, Wang Y, Lu X, Jiang W. Alginate Oligosaccharides Alleviate Salt Stress in Rice Seedlings by Regulating Cell Wall Metabolism to Maintain Cell Wall Structure and Improve Lodging Resistance. Plants (Basel). 2024;13(9).
Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, et al. ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Rep. 2024;43(3):113927.
Hayward B, Kumari D, van Karnebeek CDM, van Kuilenburg ABP, Usdin K. All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency. bioRxiv. 2024.
Yang P, Lou Y, Geng Z, Guo Z, Wu S, Li Y, Song K, Shi T, Zhang S, Xiong J, et al. Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy. Circulation. 2024.
Attia SHassan, Saadawy SF, El-Mahroky SM, Nageeb MM. Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn Schmiedebergs Arch Pharmacol. 2024.
Riyadi SAmalia, Naini AArofatus, Mayanti T, Lesmana R, Azmi MNurul, Fajriah S, Jungsuttiwong S, Supratman U. Alliaxylines A-E: five new mexicanolides from the stem barks of Dysoxylum alliaceum (Blume) Blume ex A.Juss. J Nat Med. 2024.
Saha A, Palchaudhuri R, Lanieri L, Hyzy S, Riddle MJ, Panthera J, Eide C, Tolar J, Panoskaltsis-Mortari A, Gorfinkel L, et al. Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood. 2024.
Çam SBurak, Ciftci E, Gürbüz N, Altun B, Korkusuz P. Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment window. Stem Cell Res Ther. 2024;15(1):105.
Heim D, Baldomero H, Medinger M, Masouridi-Levrat S, Schanz U, Nair G, Güngör T, Halter J, Passweg JR, Chalandon Y. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs. Swiss Med Wkly. 2024;154:3754.
Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, Tischer J, Bornhäuser M, Bethge W, et al. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2024.
Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SSi, Deal CL, et al. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a PIDTC study. J Allergy Clin Immunol. 2024.
da Silva PCristina L, Muzzi GCampos, Vilela MRibeiro, Fabreti-Oliveira RA. Allogeneic hematopoietic stem cell transplantation: A single-center experience, 2017 to 2021. Transpl Immunol. 2024:101989.
Riedel A, Faul C, Reuss K, Schröder J, Lang P, Lengerke C, Weissert N, Hengel H, Gröschel S, Schoels L, et al. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Metachromatic Leukodystrophy (MLD): A Case Series. Blood Adv. 2024.
Klimentova M, Perminova M, Shelikhova L, Abugova Y, Kobyzeva D, Pershin D, Balashov D, Myakova N, Maschan A, Maschan M. Allogeneic hematopoietic stem cell transplantation for mature T/NK-cell lymphomas in children. Transplant Cell Ther. 2024.
Schöneberger V, Tahmaz V, Matthaei M, Roters S, Schlereth SL, Schaub F, Cursiefen C, Bachmann BO. Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)-A novel surgical technique in corneal stromal disease and limbal stem cell deficiency. PLoS One. 2024;19(2):e0298241.
Toffoli EC, van Vliet AA, Forbes C, Arns AJ, Verheul HWM, Tuynman J, van der Vliet HJ, Spanholtz J, de Gruijl TD. Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions. Clin Exp Immunol. 2024.
Houkin K, Osanai T, Uchiyama S, Minematsu K, Taguchi A, Maruichi K, Niiya Y, Asaoka K, Kuga Y, Takizawa K, et al. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial. JAMA Neurol. 2024.
B Grønvold L, Ali MMohamed, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IWeum, Tjønnfjord GErland, Myhre AEivind, Fløisand Y, Gedde-Dahl T. Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors. EJHaem. 2024;5(1):117-124.
Mercadal S, Mussetti A, Lee CJ, Arevalo C, Odstrcil SM, Peña E, Sureda A, Couriel DR. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature. Ann Hematol. 2024.
Hu L, Li Z, Yang S, Zhao T, Duan W, Qin Y, Jia J, Wang J, Lu S, Jiang H, et al. Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia. Ann Hematol. 2024.
Goyal A, Foss F. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma. Expert Rev Anticancer Ther. 2024.
Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, et al. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy. 2024.
Shamsian BShahin, Momtazmanesh N, Saneifard H, Tabatabaei SMohammad T, Jafari M, Pour ZKhafaf, Al-Hussieni KJasim Moha, Jamee M, Kamfar S. Allogenic hematopoietic stem cell transplantation in an Iranian patient with osteopetrosis caused by carbonic anhydrase II deficiency: A case report. Pediatr Transplant. 2024;28(3):e14689.
Gao L, Yang L, Zhou S, Zhu W, Han Y, Chen S, Xue S, Wang Y, Qiu H, Wu D, et al. Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study. Stem Cell Res Ther. 2024;15(1):24.

Pages